This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurogenetics  • Neurology, Other  • Pediatrics  • Pediatrics, Other  • Liver/ Biliary Tract/ Pancreatic Diseases  • Genetic Disorders  • Alert me on articles by topic

Novel MPV17 Mutations

Antonella Spinazzola, MD; René Santer, MD; Orhan H. Akman, PhD; Kostas Tsiakas, MD; Hansjoerg Schaefer, MD; Xiaoqi Ding, MD; Charalampos L. Karadimas, MD; Sara Shanske, PhD; Jaya Ganesh, MD; Salvatore Di Mauro, MD; Massimo Zeviani, MD, PhD

Arch Neurol. 2008;65(8):1108-1113.

Background  Autosomal recessive mutations in MPV17 (OMIM *137960) have been identified in the hepatocerebral form of mitochondrial DNA depletion syndrome (MDS).

Objective  To describe the clinical, morphologic, and genetic findings in 3 children with MPV17-related MDS from 2 unrelated families.

Design  Case report.

Setting  Academic research.

Main Outcome Measures  We identified 3 novel pathogenic mutations in 3 children.

Results  Two children were homozygous for nonsense mutation p.W120X. A third child was compound heterozygous for missense mutation p.G24W and for a macrodeletion spanning MPV17 exon 8. All patients demonstrated lactic acidosis, hypoglycemia, hepatomegaly, and progressive liver failure. Neurologic symptoms manifested at a later stage of the disease. Death occurred within the first year of life in all 3 patients.

Conclusions  These data confirm that MPV17 mutations are associated with a 2-stage syndrome. The first symptoms are metabolic and rapidly progress to hepatic failure. This stage is followed by neurologic involvement affecting the central and peripheral systems.

Author Affiliations: Unit of Molecular Neurogenetics, Pierfranco and Luisa Mariani Center for the Study of Children's Mitochondrial Disorders, "C. Besta" Neurological Institute Foundation, Milan, Italy (Drs Spinazzola and Zeviani); Departments of Pediatrics (Drs Santer and Tsiakas), Pathology (Dr Schaefer), and Neuroradiology (Dr Ding), University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Neurology, Columbia University Medical Center, New York, New York (Drs Akman, Karadimas, Shanske, and Di Mauro); and Department of Metabolism and Genetics, University of Pennsylvania School of Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania (Dr Ganesh).

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2008;65(8):1013-1014.
FULL TEXT